Page last updated: 2024-09-03

l 733060 and Psoriasis

l 733060 has been researched along with Psoriasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alysandratos, KD; Angelidou, A; Asadi, S; Conti, P; Kalogeromitros, D; Kempuraj, D; Leeman, S; Peterson, E; Stavrianeas, N; Tagen, M; Theoharides, TC; Vasiadi, M; Zhang, B	1

Other Studies

1 other study(ies) available for l 733060 and Psoriasis

Article	Year
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proceedings of the National Academy of Sciences of the United States of America, 2010, Mar-02, Volume: 107, Issue:9 Topics: Calcium; Cytosol; Humans; Immunohistochemistry; Interleukin-33; Interleukins; Mast Cells; Neurokinin-1 Receptor Antagonists; Piperidines; Psoriasis; RNA, Messenger; Skin; Substance P; Vascular Endothelial Growth Factor A	2010

Article

Year

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Proceedings of the National Academy of Sciences of the United States of America, 2010, Mar-02, Volume: 107, Issue:9

Topics: Calcium; Cytosol; Humans; Immunohistochemistry; Interleukin-33; Interleukins; Mast Cells; Neurokinin-1 Receptor Antagonists; Piperidines; Psoriasis; RNA, Messenger; Skin; Substance P; Vascular Endothelial Growth Factor A

2010